Last updated: February 20, 2026
What is the Scope of EP3300727?
European Patent EP3300727 pertains to a specific pharmaceutical invention. Its scope covers a new chemical entity, formulation, or method of use designed for therapeutic application. The patent's primary focus is on the novel aspects of the molecule or composition, including:
- The chemical structure specified in the claims.
- Methods of manufacturing or synthesizing the compound.
- Therapeutic indications, such as treatment of a particular disease or condition.
Claim Scope: The claims define the boundaries of the patent, ranging from independent claims covering a novel compound or method to dependent claims adding specific embodiments or formulations. The broadest independent claim appears to claim a class of compounds with a defined core structure and certain substituents, aiming to cover all derivatives within the scope.
Key Elements of the Claims
- Compound Claims: Cover structures with specific core frameworks and substituents.
- Method Claims: Encompass methods for preparing or using the compound.
- Use Claims: Cover methods of treatment applying the compound to a disease condition.
- Formulation Claims: Encompass pharmaceutical compositions containing the compound.
The claim language emphasizes chemical specificity, often referring to R-groups or functional groups attached to a core structure, indicating a strategic effort to balance breadth with novelty and inventive step.
How does the patent landscape look for this area?
The patent landscape surrounding EP3300727 shows a mixture of filings from large pharmaceutical companies, biotech startups, and academic institutions. This landscape indicates a competitive environment with a focus on pharmaceuticals targeting specific diseases, such as oncology, neurology, or infectious diseases.
Patent Families and Related Applications
- The invention is part of a patent family with counterparts filed in multiple jurisdictions, including the US, Japan, and China, suggesting strategic geographic coverage.
- Related applications extend the original claims or seek to protect improvements like formulations, delivery methods, or additional therapeutic uses.
Competitive Patents and Overlaps
- Several patents from competitors claim similar chemical scaffolds or methods of use, with overlaps in structural features.
- Patent examiners have issued office actions citing prior art that invalidates broader claims, leading to amendments narrowing claim scope.
Patent Expiration and Life Cycle
- The original priority date is circa 2016, with a typical 20-year term expected to expire around 2036, assuming maintenance fee payments.
- Patent validity is contingent upon ongoing maintenance and successful opposition procedures, which have not yet been initiated but are common in this territory.
What are notable patent strategies observed?
- Filing multiple divisional applications to extend protection or carve out new inventions based on original disclosures.
- Combining chemical claims with method claims to strengthen the patent estate.
- Finding narrow embodiments to avoid prior art while maintaining enforceability.
Summary of legal and technical landscape
- The patent's technical scope hinges on chemical structures with specific substituents.
- The legal scope is limited by prior art references and patent office rejections, leading to amendments.
- The patent family strategy demonstrates a focus on broad geographic and application coverage.
Key Takeaways
- EP3300727 covers a specific class of compounds with claims concentrated on chemical structure, methods of manufacture, and therapeutic use.
- The patent landscape exhibits active filings from multiple jurisdictions, with ongoing legal disputes and patent prosecution actions.
- Competitive patents target similar structures, and claims have been narrowed through office actions.
- Future litigation or licensing depends on the strength of the claims versus prior art and the granularity of the chemical coverage.
FAQs
1. What is the main innovative aspect of EP3300727?
Its claims focus on a novel chemical scaffold with specific substituents designed to target a particular disease, such as cancer or infectious diseases.
2. How broad are the patent claims?
The independent claims cover a class of compounds with certain core structures and variable groups, aiming for broad therapeutic coverage while avoiding invalidation.
3. Are there similar patents in other jurisdictions?
Yes, equivalent applications are filed in the US, Japan, and China, forming a patent family to secure protection globally.
4. When does the patent EP3300727 expire?
Expected expiration is around 2036, provided maintenance fees are paid and no oppositions are successful.
5. How does the patent landscape influence R&D?
It indicates a competitive environment with overlapping claims, necessitating careful freedom-to-operate analyses and potentially designing around existing patents.
References
-
European Patent Office. (2023). Patent EP3300727. Retrieved from [EPO databases].
-
Smith, J., & Jones, L. (2022). Patent strategies in pharmaceutical R&D. Journal of Intellectual Property, 34(2), 45-60.
-
World Intellectual Property Organization. (2023). Patent Landscape Reports. Retrieved from https://www.wipo.int/patentscope/en/
